Business Description
VolitionRX Ltd
NAICS : 325413
SIC : 2836
ISIN : US9286611077
Description
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.54 | |||||
| Equity-to-Asset | -0.28 | |||||
| Debt-to-Equity | -0.75 | |||||
| Debt-to-EBITDA | -0.17 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -13.51 | |||||
| Beneish M-Score | -4.06 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -4 | |||||
| 3-Year EPS without NRI Growth Rate | -3.3 | |||||
| 3-Year FCF Growth Rate | 12.8 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 78.81 | |||||
| 9-Day RSI | 70.45 | |||||
| 14-Day RSI | 62.83 | |||||
| 6-1 Month Momentum % | 2.01 | |||||
| 12-1 Month Momentum % | -53.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.69 | |||||
| Quick Ratio | 0.69 | |||||
| Cash Ratio | 0.65 | |||||
| Days Sales Outstanding | 62.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19 | |||||
| Shareholder Yield % | -38.27 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -4615.87 | |||||
| Net Margin % | -4557.29 | |||||
| FCF Margin % | -2470.58 | |||||
| ROA % | -160.7 | |||||
| ROIC % | -177.15 | |||||
| ROC (Joel Greenblatt) % | -593.68 | |||||
| ROCE % | -2542.38 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 91.37 | |||||
| EV-to-EBIT | -1.7 | |||||
| EV-to-EBITDA | -1.77 | |||||
| EV-to-Revenue | 77.57 | |||||
| EV-to-Forward-Revenue | 8.72 | |||||
| EV-to-FCF | -3.14 | |||||
| Earnings Yield (Greenblatt) % | -58.82 | |||||
| FCF Yield % | -25.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:VNRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
VolitionRX Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.775 | ||
| EPS (TTM) ($) | -0.51 | ||
| Beta | 1.32 | ||
| Volatility % | 74.53 | ||
| 14-Day RSI | 62.83 | ||
| 14-Day ATR ($) | 0.084634 | ||
| 20-Day SMA ($) | 0.728328 | ||
| 12-1 Month Momentum % | -53.14 | ||
| 52-Week Range ($) | 0.55 - 2.1 | ||
| Shares Outstanding (Mil) | 82.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
VolitionRX Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
VolitionRX Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
VolitionRX Ltd Frequently Asked Questions
What is VolitionRX Ltd(VNRX)'s stock price today?
The current price of VNRX is $0.91. The 52 week high of VNRX is $2.10 and 52 week low is $0.55.
When is next earnings date of VolitionRX Ltd(VNRX)?
The next earnings date of VolitionRX Ltd(VNRX) is 2024-05-10 Est..
Does VolitionRX Ltd(VNRX) pay dividends? If so, how much?
VolitionRX Ltd(VNRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers